Medline INC 8-K filings

Medline Inc. announced second quarter and first six months 2026 results, showing an 11.6% increase in net sales to $7.7 billion but a 58.3% decrease in net income to $139 million.

Medline Inc. announced the upcoming retirement of its Chief Operating Officer, Stephen L. Miller, effective August 30, 2026, due to health-related reasons.

Medline Inc. successfully concluded its 2026 Annual Meeting, with shareholders electing all 12 director nominees and ratifying executive compensation and auditor selection.

Medline Borrower LP and Medline Co-Issuer Inc. have issued $1.25 billion in 5.000% Senior Secured Notes due 2031 and $750 million in 5.250% Senior Secured Notes due 2033, refinancing existing debt.

Medline Inc. announced first quarter 2026 results, with net sales increasing 10.7% to $7.4 billion, while net income decreased 25.8% to $239 million, prompting a raise in full-year organic sales guidance.

Medline Inc. announced robust fourth quarter and full year 2025 net sales growth and the completion of its Initial Public Offering, despite a notable decrease in net income driven by higher costs.